List of Nitrolingual drug patents

Nitrolingual is owned by Pohl Boskamp.

Nitrolingual contains Nitroglycerin.

Nitrolingual has a total of 1 drug patent out of which 0 drug patents have expired.

Nitrolingual was authorised for market use on 31 October, 1985.

Nitrolingual is available in spray, metered;sublingual dosage forms.

Nitrolingual can be used as method of treating angina pectoris.

The generics of Nitrolingual are possible to be released after 12 March, 2029.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7872049 POHL BOSKAMP Long-term stable pharmaceutical preparation containing the active ingredient glyceryl trinitrate
Mar, 2029

(6 years from now)

Drugs and Companies using NITROGLYCERIN ingredient

Market Authorisation Date: 31 October, 1985

Treatment: Method of treating angina pectoris

Dosage: SPRAY, METERED;SUBLINGUAL

How can I launch a generic of NITROLINGUAL before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in